sameAs
Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARĪ³-mediated mechanisms in Alzheimer's disease modelsCOX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitroStereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptorsDesign, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxinsLipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivoRvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitisLipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cellsAspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cellsAspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammationResolvin D1 binds human phagocytes with evidence for proresolving receptorsLocal and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivoMaresin 1 biosynthesis during platelet-neutrophil interactions is organ-protectiveGlutamatergic neurons in rodent models respond to nanoscale particulate urban air pollutants in vivo and in vitroRapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisResolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitisElovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrityLipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantationNovel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental strokeAvermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders.Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammationResolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance.Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs.Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.Resolvins and protectins in inflammation resolution.Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomerIvermectin reduces alcohol intake and preference in mice.Cystic fibrosis and lipoxins.Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury.Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry.Synthesis of 2H-chromenes and 1,2-dihydroquinolines from aryl aldehydes, amines, and alkenylboron compounds.Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages.
P50
Q21135583-920672DD-B678-4421-A931-6EF8B9FAFD94Q21245723-22ADF352-CF2D-45B9-9DDD-1C491F0DE915Q24297600-29116350-79EC-42C2-A959-FBED5FF89A9AQ24669767-C52E25FD-4F0E-41C4-A7AF-7EF04E9F1B71Q28187049-26A1DDFC-4183-48EF-A44E-1CAE50149418Q28193788-9982B402-B476-4CDD-A1DF-F30A52E3D7C2Q28194105-A7613D66-CB6F-4683-8F69-179234275CA1Q28194980-C764FD40-ED6A-47E0-9FC4-20BA3880269AQ28196391-D42F769A-E694-4E47-A6A8-D02681D07F3BQ28213657-C2ECD815-A5D2-4A3D-882D-C841ABB013B8Q28270638-2E24D6B5-4DE3-436C-828C-D064572AA5F4Q28343427-C96FB567-9288-411C-ABA5-953F6E9C81F1Q28383169-3FDAE9C2-923E-4D0F-87FC-7384821F33DAQ28742356-5E7594D4-ED7E-444F-A7D8-D5404476BB1AQ30486807-2011EFFF-9336-4A14-9E72-747F932115D3Q31030116-3F07B0F1-629F-40C9-9B4C-DCA702B54875Q33513370-1235D5AD-2DE6-47F8-9825-A0F40B107BA7Q33785525-77B85285-578F-4F8E-9E89-5917CD537DB4Q33902944-7E968005-19FB-42EA-96EE-A472AE7B38D7Q34192460-D0B3B849-9E39-469A-B277-02D18BFF6D6AQ34199527-F603AB11-1F6A-4541-8DDE-FEFAA614396BQ34230865-EAD75304-24C2-4FF5-8621-2003F673E10EQ34250276-8E37788E-E87A-47B3-BA0E-E6302415D2AEQ34407070-0533789F-CAFA-453A-AD67-97D70F70186CQ34413165-890A929E-6B58-4BFB-B6C9-722F93ECAE8EQ34455625-73CB47DC-9627-4599-89A1-6513C8CED099Q34508024-C07BCEE9-3E5F-43DF-A0AF-2F020D799480Q34618673-8F193849-849F-4452-B42C-0813E7FB867DQ34743086-D78ABA34-FEDD-40DF-854E-3D19B2FDB677Q34936308-B942F3A9-3CA5-4785-95DB-B5E74EA34D5DQ35008940-2E97E5A4-A29B-4CDF-8108-1A80B9698A1BQ35332873-512472CD-C9D5-46CD-8863-92E3E2E60F9EQ36018475-11A17B26-2487-4927-B743-FEF9C8A75499Q36024293-63B955D8-853A-4839-B37C-2AAF4D01C375Q36175653-09F135CC-C78E-4489-9CB7-8DA221726E3CQ36228479-4EB8588A-A3A6-4323-99CC-DFF849BA081AQ36581707-0FCB13F7-B1EA-434A-ACE6-6A3E31CAB83BQ36889907-9641565E-F2BE-4DA1-9CEC-8063A0D7ED7BQ37240909-75371EBF-5864-4985-8A82-1CA602DDD78AQ37379884-327FD67A-A025-408E-BAAF-D5DD60691A78
P50
description
amerikanisch-zypriotischer Chemiker
@de
scheikundige
@nl
scientist
@en
name
Nicos A. Petasis
@af
Nicos A. Petasis
@an
Nicos A. Petasis
@ast
Nicos A. Petasis
@bar
Nicos A. Petasis
@br
Nicos A. Petasis
@ca
Nicos A. Petasis
@co
Nicos A. Petasis
@cs
Nicos A. Petasis
@cy
Nicos A. Petasis
@da
type
label
Nicos A. Petasis
@af
Nicos A. Petasis
@an
Nicos A. Petasis
@ast
Nicos A. Petasis
@bar
Nicos A. Petasis
@br
Nicos A. Petasis
@ca
Nicos A. Petasis
@co
Nicos A. Petasis
@cs
Nicos A. Petasis
@cy
Nicos A. Petasis
@da
altLabel
Nicos Petasis
@af
Nicos Petasis
@an
Nicos Petasis
@ast
Nicos Petasis
@bar
Nicos Petasis
@br
Nicos Petasis
@ca
Nicos Petasis
@co
Nicos Petasis
@cs
Nicos Petasis
@cy
Nicos Petasis
@da
prefLabel
Nicos A. Petasis
@af
Nicos A. Petasis
@an
Nicos A. Petasis
@ast
Nicos A. Petasis
@bar
Nicos A. Petasis
@br
Nicos A. Petasis
@ca
Nicos A. Petasis
@co
Nicos A. Petasis
@cs
Nicos A. Petasis
@cy
Nicos A. Petasis
@da
P1006
P214
P244
P1006
P1053
B-3162-2009
P106
P1153
7005112630
P19
P21
P213
0000 0000 2667 6958
P214
P2381
P244
P2798
P31
P3829
P496
0000-0002-8864-4446
P569
1954-01-01T00:00:00Z